TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,076,298 | +50.2% | 4,050,865 | 0.0% | 2.53% | +49.6% |
| Q4 2022 | $4,046,814 | -44.5% | 4,050,865 | 0.0% | 1.69% | -39.0% |
| Q3 2022 | $7,292,000 | -37.9% | 4,050,865 | 0.0% | 2.78% | -44.0% |
| Q2 2022 | $11,748,000 | +5.1% | 4,050,865 | 0.0% | 4.96% | +29.7% |
| Q1 2022 | $11,180,000 | -40.8% | 4,050,865 | 0.0% | 3.82% | -6.3% |
| Q4 2021 | $18,877,000 | -45.2% | 4,050,865 | 0.0% | 4.08% | -48.9% |
| Q3 2021 | $34,473,000 | -48.1% | 4,050,865 | 0.0% | 7.99% | -35.4% |
| Q2 2021 | $66,475,000 | -25.7% | 4,050,865 | 0.0% | 12.36% | -28.5% |
| Q1 2021 | $89,443,000 | -28.6% | 4,050,865 | 0.0% | 17.28% | -2.5% |
| Q4 2020 | $125,293,000 | +52.2% | 4,050,865 | 0.0% | 17.73% | +15.5% |
| Q3 2020 | $82,314,000 | +32.3% | 4,050,865 | 0.0% | 15.35% | -17.1% |
| Q2 2020 | $62,221,000 | +98.4% | 4,050,865 | 0.0% | 18.51% | -2.9% |
| Q1 2020 | $31,354,000 | -45.8% | 4,050,865 | 0.0% | 19.07% | -25.1% |
| Q4 2019 | $57,846,000 | -5.0% | 4,050,865 | 0.0% | 25.46% | -2.3% |
| Q3 2019 | $60,885,000 | +5.0% | 4,050,865 | 0.0% | 26.06% | +11.2% |
| Q2 2019 | $57,968,000 | -17.9% | 4,050,865 | 0.0% | 23.42% | -19.5% |
| Q1 2019 | $70,607,000 | – | 4,050,865 | – | 29.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|